Mirova’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-221
| Closed | -$213K | – | 146 |
|
2024
Q1 | $213K | Hold |
221
| – | – | 0.04% | 106 |
|
2023
Q4 | $194K | Sell |
221
-11
| -5% | -$9.66K | 0.04% | 83 |
|
2023
Q3 | $191K | Sell |
232
-366
| -61% | -$301K | 0.04% | 90 |
|
2023
Q2 | $430K | Sell |
598
-623
| -51% | -$448K | 0.08% | 97 |
|
2023
Q1 | $1M | Buy |
1,221
+663
| +119% | +$545K | 0.14% | 86 |
|
2022
Q4 | $403K | Sell |
558
-583
| -51% | -$421K | 0.06% | 121 |
|
2022
Q3 | $786K | Sell |
1,141
-640
| -36% | -$441K | 0.13% | 96 |
|
2022
Q2 | $1.05M | Buy |
1,781
+1,104
| +163% | +$652K | 0.15% | 85 |
|
2022
Q1 | $472K | Sell |
677
-11
| -2% | -$7.67K | 0.06% | 123 |
|
2021
Q4 | $434K | Sell |
688
-1,140
| -62% | -$719K | 0.05% | 124 |
|
2021
Q3 | $1.11M | Buy |
1,828
+166
| +10% | +$100K | 0.14% | 80 |
|
2021
Q2 | $928K | Buy |
1,662
+100
| +6% | +$55.8K | 0.11% | 77 |
|
2021
Q1 | $739K | Buy |
1,562
+216
| +16% | +$102K | 0.09% | 89 |
|
2020
Q4 | $650K | Buy |
1,346
+1,281
| +1,971% | +$619K | 0.08% | 82 |
|
2020
Q3 | $36K | Buy |
+65
| New | +$36K | 0.01% | 144 |
|